Figure 1 shows a case of BRAF-mutated MM patient, with a diffusely metastatic disease at staging, showing metabolic response at 18F-FDG PET/CT after anti BRAF/MEK therapy. Here, MAP2K7 is linked to Miyoshi myopathy.